-
公开(公告)号:EP3405041A1
公开(公告)日:2018-11-28
申请号:EP17741157.6
申请日:2017-01-17
发明人: MEHTA, Dilip , DE SOUZA, Anselm
IPC分类号: A23C9/123 , A23C9/127 , A61K35/74 , A61K35/742 , A61K35/747 , C12N1/20
CPC分类号: A23L33/14 , A23L33/135 , A23V2002/00 , A23V2200/3204 , A23V2250/032 , A23V2250/51082 , A23V2250/628 , A23Y2220/03 , A23Y2220/17 , A61K35/742 , A61K35/747
摘要: The present invention provides a stable liquid syrup composition compositions comprising probiotic bacteria, retaining their cellular viability at ambient storage conditions for at least two years.
-
公开(公告)号:EP3386523A1
公开(公告)日:2018-10-17
申请号:EP16820183.8
申请日:2016-12-09
IPC分类号: A61K35/745
CPC分类号: A61K35/745 , A23L33/135 , A23L33/30 , A23V2002/00 , A23V2200/3204 , A23V2200/332 , A61P3/04 , C12N1/20 , C12R1/01
摘要: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
-
公开(公告)号:EP1784222B1
公开(公告)日:2018-10-10
申请号:EP05775158.8
申请日:2005-08-24
申请人: N.V. Nutricia
发明人: BOEHM, Günther , M'RABET, Laura , STAHL, Bernd , GARSSEN, Johan
IPC分类号: A61K39/42 , A61K31/702 , A61K31/202 , A61K35/74 , A61P11/00 , A61P31/00
CPC分类号: A61K31/702 , A23L33/12 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2300/29 , A61K31/202 , A61K31/733 , A61K35/741 , A61K39/42 , A61K2300/00 , A23V2200/324 , A23V2250/28 , A23V2250/608 , A23V2250/304 , A23V2250/1642 , A23V2250/1882 , A23V2200/3202 , A23V2200/3204
摘要: The present invention provides a method and composition for the treatment and/or prevention of respiratory tract infection and/or respiratory tract infection disease, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and at least 5 wt.% digestible galactose saccharide.
-
公开(公告)号:EP2805625B1
公开(公告)日:2018-10-03
申请号:EP14181368.3
申请日:2006-02-28
申请人: N.V. Nutricia
发明人: Knol, Jan , Haarman, Monique , Garssen, Johan , Vriesema, Adrianus Johannes Maria , Alles, Martine Sandra
IPC分类号: A23L33/21 , A23L33/10 , A23L33/135 , A61K31/715 , A61P1/12 , A61P37/08
CPC分类号: A23L1/296 , A23L1/3014 , A23L1/308 , A23L33/135 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A23Y2300/29 , A61K9/0095 , A61K31/715 , A61K35/742 , A61K35/745 , A61K35/747 , A23V2200/3202 , A23V2250/5062 , A23V2200/3204 , A23V2200/304 , A23V2200/328 , A61K2300/00
摘要: A composition comprising 5 to 16 en.% protein, 30 to 60 en.% fat, and 25 to 75 en.% carbohydrates and comprising Bifidobacterium breve and Lactobacillus paracasei and the use of said composition for the treatment and/or prevention of gastro-intestinal disorder, immune disorder and/or endocrine disorder.
-
公开(公告)号:EP2689783B1
公开(公告)日:2018-08-15
申请号:EP13190163.9
申请日:2006-10-31
发明人: Perl, Daniel P. , Moalem, Sharon
CPC分类号: A61K33/24 , A01N55/02 , A01N59/16 , A23K20/20 , A23L3/358 , A23L33/16 , A23V2002/00 , A61K8/19 , A61K8/24 , A61K8/365 , A61K31/28 , A61K2800/58 , A61L2/16 , A61L2/18 , A61L12/088 , A61L15/46 , A61L2300/102 , A61L2300/404 , A61Q11/00 , A61Q11/02 , Y02A50/473 , Y02A50/483 , A23V2200/312 , A23V2200/3204 , A23V2250/1596 , A23V2200/10
摘要: The present invention provides methods for treating or preventing diseases and disorders caused by iron-dependent pathogenic microorganisms/such as bacteria, fungi, and parasites, by applying a gallium compound to an affected area. In particular, the present invention provides methods for treating or preventing dental caries, vaginal infections, skin infections, and so forth. Gallium compounds can be formulated as toothpaste, mouthwash, cream, ointment, gel, solution, eye drops, suppository, and the toothbrush, denture, dental retainer, contact lens, catheter, food stuff, and so forth. In addition, the present invention provides animal feeds which contain gallium compounds that promote the animal growth and prevent the animals form infections as well as protect consumers from post processing infections.
-
公开(公告)号:EP2704733B1
公开(公告)日:2018-06-20
申请号:EP12727221.9
申请日:2012-05-03
申请人: LB Bulgaricum PLC
IPC分类号: A61K35/747 , A23L33/135 , C12R1/25 , C12R1/225
CPC分类号: C12R1/25 , A23L33/135 , A23V2002/00 , A23Y2220/37 , A23Y2220/39 , A23Y2220/67 , A61K35/747 , C12R1/225 , A23V2200/3204 , A23V2200/324 , A23V2200/3262
摘要: This invention relates to polybacterial probiotic preparation, which includes new strains of lactic acid bacteria Lactobacillus gasseri 7/12 NBIMCC No. 8720, Lactobacillus plantarum F12 NBIMCC No 8722 and Lactobacillus helveticus A1, NBIMCC No 8721 and has the following set of properties: antioxidant, hypocholesterolemic effect, anti-inflammatory immunomodulating effect, ability to release bioactive peptides that inhibit angiotensin-converting enzyme (ACE), which is responsible for the high blood pressure. The object of invention is also the described probiotic strains of lactic acid bacteria and the developed bacterial products with useful properties. The incorporated probiotic strain Lactobacillus gasseri 7/12 NBIMCC No. 8720, has a number of properties: strong adhesion to the epithelial layer of the colon, the ability for reduction of cholesterol and anti-inflammatory effects by reducing the levels of proinflammatory cytokine interleukin-8. The invention relates to the use of strains of lactic acid bacteria and bacterial agents in the production of starter cultures, food additives, food, functional products and pharmaceutical preparations intended to influence the health of humans and animals.
-
公开(公告)号:EP3328215A1
公开(公告)日:2018-06-06
申请号:EP16831011.8
申请日:2016-07-08
发明人: KESHTMAND, Majid , HAREL, Mordechai , RICE, Trisha
IPC分类号: A23L33/00
CPC分类号: A61K35/747 , A23L2/52 , A23L2/60 , A23L2/66 , A23L33/125 , A23L33/135 , A23L33/15 , A23L33/18 , A23L33/185 , A23L33/40 , A23V2002/00 , A23Y2220/03 , A61K9/0095 , A61K9/145 , A61K9/146 , A61K35/745 , A23V2200/3202 , A23V2200/3204 , A23V2250/507 , A23V2250/548 , A23V2250/612 , A23V2250/712
摘要: A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1×1010 CFU/g, and a viability loss of less than 1 log unit/g after 3 months at a temperature of 40° C. and a relative humidity of 33%. Also provided are methods for preparing the dry stable probiotic composition.
-
公开(公告)号:EP3212001A4
公开(公告)日:2018-04-25
申请号:EP15853671
申请日:2015-10-30
申请人: WHOLE BIOME INC
IPC分类号: A01N63/00 , A61K31/733 , A61K35/74 , A61K45/06 , C12N1/20
CPC分类号: A61K35/745 , A23L33/135 , A23V2002/00 , A61K9/0053 , A61K9/2846 , A61K9/48 , A61K9/4816 , A61K9/4891 , A61K31/00 , A61K31/733 , A61K35/74 , A61K35/741 , A61K35/742 , A61K45/06 , A61K2035/115 , C12N1/20 , C12Q1/689 , G01N33/66 , G01N2333/605 , G01N2800/04 , A61K2300/00 , A23V2200/3202 , A23V2200/3204 , A23V2200/328 , A23V2200/332
摘要: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
-
公开(公告)号:EP3289888A1
公开(公告)日:2018-03-07
申请号:EP17382031.7
申请日:2017-01-24
IPC分类号: A23L33/135 , A61K35/741 , A61K8/99
CPC分类号: A23L33/135 , A23V2002/00 , A61K8/99 , A61K35/741 , A23V2200/3204 , A23V2250/206
摘要: Health products do not meet the conditions in order for common probiotics to be preserved since they have a degree of moisture greater than 5% and/or a temperature greater than 5°C in any of the processes of production, storage and preservation and into which the inactivated probiotics have been incorporated. The inactivation of the probiotics is achieved by means of subjecting the probiotic strains to high temperatures (range 50°C to 140°C) for a time period of between 30 seconds and 90 minutes depending on the time of exposure of the bacteria to temperatures, in various consecutive sessions and with subsequent cooling to the optimal survival temperature of the bacteria. The use of inactivated probiotics allows them to be incorporated in health forms of different sectors such as: nutraceuticals, dietetics, pharmaceuticals, cosmetics and foodstuffs itself; these probiotics do not require strict temperature and moisture control.
摘要翻译: 由于健康产品在生产,储存和保存的任何过程中具有大于5%的湿度和/或大于5℃的温度,因此不符合条件以保存普通益生菌, 灭活的益生菌已被纳入。 根据细菌暴露于温度下的时间,通过使益生菌菌株经受高温(范围50℃至140℃)持续30秒至90分钟的时间段来实现益生菌的灭活, 在各种连续的过程中并随后冷却至细菌的最佳存活温度。 灭活益生菌的使用使它们能够被纳入不同部门的健康形式,如:营养品,营养食品,药品,化妆品和食品本身; 这些益生菌不需要严格的温度和湿度控制。
-
公开(公告)号:EP2586448B1
公开(公告)日:2018-02-07
申请号:EP11800786.3
申请日:2011-06-27
IPC分类号: A61K31/702 , A61K35/20 , A23C9/12 , A61K35/744 , A61K35/745 , A61P17/00 , A61P17/16 , A23L33/135
CPC分类号: A61K35/74 , A23L33/135 , A23V2002/00 , A61K31/702 , A61K35/20 , A61K35/744 , A61K35/745 , A23V2200/318 , A23V2200/3204
摘要: Disclosed is a skin property-improving agent which exerts excellent effects by oral administration. The skin property-improving agent for oral administration contains, as an active ingredient, a bacterium belonging to the genus Streptococcus and a bacterium belonging to the genus Bifidobacterium, or fermented milk containing the two bacteria.
-
-
-
-
-
-
-
-
-